Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-39.92	61.83	102.91
Graham Fair Price	6.72	1.92	1.80
PEG	-441.73	-32.33	-5.97
Price/Book	9.39	1.25	1.15
Price/Cash Flow	182.09	78.27	27.75
Prices/Earnings	55.72	417.19	267.91
Price/Sales	-65.83	18.37	53.75
Price/FCF	182.09	78.27	27.75
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-75.04	0.24	0.95
Operating Margin	-73.26	0.18	0.67
ROA	-24.92	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-29.75
ROIC	0.02	< 0.005	-86.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.31	2.37	-86.80
Dividends QOQ	< 0.005	-0.09	21246.77
EBIT QOQ	< 0.005	0.20	105507.98
EPS QOQ	-0.45	-0.13	71.26
FCF QOQ	4.42	-0.46	-89.65
Revenue QOQ	-0.02	3.48	15567.67
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	7909.92	-9.22	-99.88
Days Sales Outstanding (DSO)	182.21	49.91	-72.61
Inventory Turnover	0.01	-9.76	85666.35
Debt/Capitalization	0.53	0.50	-5.85
Quick Ratio	0.30	0.30	-1.11
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	11.61	14.78	27.33
Cash	0.25	0.34	34.02
Capex	0.06	-0.03	-48.87
Free Cash Flow	0.48	0.24	-50.62
Revenue	0.25	1.01	307.65
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.41	0.27	-33.57
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	50.31	27.87	-44.60
Naive Interpretation	Member

06 - Financial Health · Bad

Rating